TWO SIGMA INVESTMENTS, LP - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$17,033,000
-70.2%
732,908
-73.4%
0.05%
-72.6%
Q4 2017$57,221,000
+364.1%
2,753,652
+286.4%
0.19%
+313.3%
Q2 2017$12,329,000
+57.6%
712,674
+32.3%
0.04%
+50.0%
Q4 2016$7,823,000
+121.2%
538,803
+206.8%
0.03%
+100.0%
Q2 2016$3,536,000
+1132.1%
175,594
+1507.1%
0.02%
+1400.0%
Q1 2016$287,000
-98.4%
10,926
-89.5%
0.00%
-98.9%
Q3 2015$18,496,000
-71.1%
103,660
-64.1%
0.10%
-68.2%
Q2 2015$64,076,000
-34.2%
288,598
-41.2%
0.30%
-37.7%
Q1 2015$97,415,000
+643.3%
490,657
+435.7%
0.48%
+557.5%
Q4 2014$13,106,000
-86.7%
91,584
-88.3%
0.07%
-83.6%
Q2 2014$98,680,000
+121.5%
782,433
+131.5%
0.44%
+86.2%
Q1 2014$44,552,000
+5597.2%
337,951
+4973.6%
0.24%
+5875.0%
Q4 2013$782,000
-97.0%
6,661
-97.4%
0.00%
-97.6%
Q3 2013$26,267,000251,7660.17%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2013
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders